Report cover image

Global Long-acting PrEP Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 190 Pages
SKU # APRC20283158

Description

Summary

According to APO Research, The global Long-acting PrEP market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Long-acting PrEP is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Long-acting PrEP is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Long-acting PrEP is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Long-acting PrEP is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Long-acting PrEP include ViiV Healthcare and Gilead Sciences etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Long-acting PrEP, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Long-acting PrEP, also provides the sales of main regions and countries. Of the upcoming market potential for Long-acting PrEP, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long-acting PrEP sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Long-acting PrEP market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Long-acting PrEP sales, projected growth trends, production technology, application and end-user industry.

Long-acting PrEP Segment by Company

ViiV Healthcare
Gilead Sciences
Long-acting PrEP Segment by Type

Cabotegravir
Lenacapavir
Other
Long-acting PrEP Segment by Application

Hospital
Clinic
Other
Long-acting PrEP Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting PrEP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Long-acting PrEP and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting PrEP.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Long-acting PrEP in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Long-acting PrEP manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-acting PrEP sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Long-acting PrEP Market by Type
1.2.1 Global Long-acting PrEP Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cabotegravir
1.2.3 Lenacapavir
1.2.4 Other
1.3 Long-acting PrEP Market by Application
1.3.1 Global Long-acting PrEP Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Long-acting PrEP Market Dynamics
2.1 Long-acting PrEP Industry Trends
2.2 Long-acting PrEP Industry Drivers
2.3 Long-acting PrEP Industry Opportunities and Challenges
2.4 Long-acting PrEP Industry Restraints
3 Global Market Growth Prospects
3.1 Global Long-acting PrEP Revenue Estimates and Forecasts (2020-2031)
3.2 Global Long-acting PrEP Revenue by Region
3.2.1 Global Long-acting PrEP Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Long-acting PrEP Revenue by Region (2020-2025)
3.2.3 Global Long-acting PrEP Revenue by Region (2026-2031)
3.2.4 Global Long-acting PrEP Revenue Market Share by Region (2020-2031)
3.3 Global Long-acting PrEP Sales Estimates and Forecasts 2020-2031
3.4 Global Long-acting PrEP Sales by Region
3.4.1 Global Long-acting PrEP Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Long-acting PrEP Sales by Region (2020-2025)
3.4.3 Global Long-acting PrEP Sales by Region (2026-2031)
3.4.4 Global Long-acting PrEP Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Long-acting PrEP Revenue by Manufacturers
4.1.1 Global Long-acting PrEP Revenue by Manufacturers (2020-2025)
4.1.2 Global Long-acting PrEP Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Long-acting PrEP Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Long-acting PrEP Sales by Manufacturers
4.2.1 Global Long-acting PrEP Sales by Manufacturers (2020-2025)
4.2.2 Global Long-acting PrEP Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Long-acting PrEP Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Long-acting PrEP Sales Price by Manufacturers (2020-2025)
4.4 Global Long-acting PrEP Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Long-acting PrEP Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Long-acting PrEP Manufacturers, Product Type & Application
4.7 Global Long-acting PrEP Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Long-acting PrEP Market CR5 and HHI
4.8.2 2024 Long-acting PrEP Tier 1, Tier 2, and Tier 3
5 Long-acting PrEP Market by Type
5.1 Global Long-acting PrEP Revenue by Type
5.1.1 Global Long-acting PrEP Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Long-acting PrEP Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Long-acting PrEP Revenue Market Share by Type (2020-2031)
5.2 Global Long-acting PrEP Sales by Type
5.2.1 Global Long-acting PrEP Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Long-acting PrEP Sales by Type (2020-2031) & (K Units)
5.2.3 Global Long-acting PrEP Sales Market Share by Type (2020-2031)
5.3 Global Long-acting PrEP Price by Type
6 Long-acting PrEP Market by Application
6.1 Global Long-acting PrEP Revenue by Application
6.1.1 Global Long-acting PrEP Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Long-acting PrEP Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Long-acting PrEP Revenue Market Share by Application (2020-2031)
6.2 Global Long-acting PrEP Sales by Application
6.2.1 Global Long-acting PrEP Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Long-acting PrEP Sales by Application (2020-2031) & (K Units)
6.2.3 Global Long-acting PrEP Sales Market Share by Application (2020-2031)
6.3 Global Long-acting PrEP Price by Application
7 Company Profiles
7.1 ViiV Healthcare
7.1.1 ViiV Healthcare Comapny Information
7.1.2 ViiV Healthcare Business Overview
7.1.3 ViiV Healthcare Long-acting PrEP Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 ViiV Healthcare Long-acting PrEP Product Portfolio
7.1.5 ViiV Healthcare Recent Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Comapny Information
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Long-acting PrEP Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Gilead Sciences Long-acting PrEP Product Portfolio
7.2.5 Gilead Sciences Recent Developments
8 North America
8.1 North America Long-acting PrEP Market Size by Type
8.1.1 North America Long-acting PrEP Revenue by Type (2020-2031)
8.1.2 North America Long-acting PrEP Sales by Type (2020-2031)
8.1.3 North America Long-acting PrEP Price by Type (2020-2031)
8.2 North America Long-acting PrEP Market Size by Application
8.2.1 North America Long-acting PrEP Revenue by Application (2020-2031)
8.2.2 North America Long-acting PrEP Sales by Application (2020-2031)
8.2.3 North America Long-acting PrEP Price by Application (2020-2031)
8.3 North America Long-acting PrEP Market Size by Country
8.3.1 North America Long-acting PrEP Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Long-acting PrEP Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Long-acting PrEP Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Long-acting PrEP Market Size by Type
9.1.1 Europe Long-acting PrEP Revenue by Type (2020-2031)
9.1.2 Europe Long-acting PrEP Sales by Type (2020-2031)
9.1.3 Europe Long-acting PrEP Price by Type (2020-2031)
9.2 Europe Long-acting PrEP Market Size by Application
9.2.1 Europe Long-acting PrEP Revenue by Application (2020-2031)
9.2.2 Europe Long-acting PrEP Sales by Application (2020-2031)
9.2.3 Europe Long-acting PrEP Price by Application (2020-2031)
9.3 Europe Long-acting PrEP Market Size by Country
9.3.1 Europe Long-acting PrEP Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Long-acting PrEP Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Long-acting PrEP Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Long-acting PrEP Market Size by Type
10.1.1 China Long-acting PrEP Revenue by Type (2020-2031)
10.1.2 China Long-acting PrEP Sales by Type (2020-2031)
10.1.3 China Long-acting PrEP Price by Type (2020-2031)
10.2 China Long-acting PrEP Market Size by Application
10.2.1 China Long-acting PrEP Revenue by Application (2020-2031)
10.2.2 China Long-acting PrEP Sales by Application (2020-2031)
10.2.3 China Long-acting PrEP Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Long-acting PrEP Market Size by Type
11.1.1 Asia Long-acting PrEP Revenue by Type (2020-2031)
11.1.2 Asia Long-acting PrEP Sales by Type (2020-2031)
11.1.3 Asia Long-acting PrEP Price by Type (2020-2031)
11.2 Asia Long-acting PrEP Market Size by Application
11.2.1 Asia Long-acting PrEP Revenue by Application (2020-2031)
11.2.2 Asia Long-acting PrEP Sales by Application (2020-2031)
11.2.3 Asia Long-acting PrEP Price by Application (2020-2031)
11.3 Asia Long-acting PrEP Market Size by Country
11.3.1 Asia Long-acting PrEP Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Long-acting PrEP Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Long-acting PrEP Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Long-acting PrEP Market Size by Type
12.1.1 SAMEA Long-acting PrEP Revenue by Type (2020-2031)
12.1.2 SAMEA Long-acting PrEP Sales by Type (2020-2031)
12.1.3 SAMEA Long-acting PrEP Price by Type (2020-2031)
12.2 SAMEA Long-acting PrEP Market Size by Application
12.2.1 SAMEA Long-acting PrEP Revenue by Application (2020-2031)
12.2.2 SAMEA Long-acting PrEP Sales by Application (2020-2031)
12.2.3 SAMEA Long-acting PrEP Price by Application (2020-2031)
12.3 SAMEA Long-acting PrEP Market Size by Country
12.3.1 SAMEA Long-acting PrEP Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Long-acting PrEP Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Long-acting PrEP Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Long-acting PrEP Value Chain Analysis
13.1.1 Long-acting PrEP Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Long-acting PrEP Production Mode & Process
13.2 Long-acting PrEP Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Long-acting PrEP Distributors
13.2.3 Long-acting PrEP Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.